Polymorphism of the multidrug resistance 1 gene MDR1/ABCB1 C3435T and response to antiepileptic drug treatment in temporal lobe epilepsy

Seizure

Volumn 24, Issue C, 2015, Pages 124-126

  Manna, Ida ^a   Gambardella, Antonio ^b   Labate, Angelo ^b   Mumoli, Laura ^b   Ferlazzo, Edoardo ^c   Pucci, Franco ^b   Aguglia, Umberto ^b,c   Quattrone, Aldo ^a,b  

^a CNR   (Italy)

^b UNIVERSITY MAGNA GRAECIA OF CATANZARO   (Italy)

^c Hospital of Reggio Calabria   (Italy)

Author keywords

Antiepileptic drugs; Association studies; MDR1; Pharmacogenetics; Single nucleotide polymorphism; Temporal lobe epilepsy

Indexed keywords

CARBAMAZEPINE; GENOMIC DNA; LAMOTRIGINE; MULTIDRUG RESISTANCE PROTEIN 1; OXCARBAZEPINE; TOPIRAMATE; ANTICONVULSIVE AGENT; MULTIDRUG RESISTANCE PROTEIN;

ADULT; ARTICLE; CONTROLLED STUDY; DRUG RESPONSE; ENVIRONMENTAL FACTOR; ETHNICITY; FEMALE; GENE FREQUENCY; GENETIC ASSOCIATION; GENETIC VARIABILITY; GENOTYPE; HUMAN; MAJOR CLINICAL STUDY; MALE; MONOTHERAPY; PRIORITY JOURNAL; SINGLE NUCLEOTIDE POLYMORPHISM; TEMPORAL LOBE EPILEPSY; AGED; CASE CONTROL STUDY; CHI SQUARE DISTRIBUTION; EPILEPSY, TEMPORAL LOBE; GENETICS; MIDDLE AGED; NUCLEOTIDE SEQUENCE; PHARMACOGENETICS;

ADULT; AGED; ANTICONVULSANTS; CASE-CONTROL STUDIES; CHI-SQUARE DISTRIBUTION; DNA MUTATIONAL ANALYSIS; EPILEPSY, TEMPORAL LOBE; FEMALE; GENE FREQUENCY; GENOTYPE; HUMANS; MALE; MIDDLE AGED; P-GLYCOPROTEIN; PHARMACOGENETICS; POLYMORPHISM, SINGLE NUCLEOTIDE;

EID: 84927716277     PISSN: 10591311     EISSN: 15322688     Source Type: Journal    
DOI: 10.1016/j.seizure.2014.09.010     Document Type: Article

References (12)

1. Browne TR, Holmes GL. Epilepsy. N Engl J Med 2001;344:1145-51.
2. Elger CE, Schmidt D. Modern management of epilepsy: A practical approach. Epilepsy Behav 2008;12:501-39.
3. Regesta G, Tanganelli P. Clinical aspects and biological bases of drug-resistant epilepsies. Epilepsy Res 1999;34:109-22.
4. Remy S, Beck H. Molecular and cellular mechanisms of pharmacoresistance in epilepsy. Brain 2006;129:18-35.
5. Lazarowski A, Czornyj L. Potential role of multidrug resistant proteins in refractory epilepsy and antiepileptic drugs interactions. Drug Metab Drug Interact 2011;26:21-6.
6. Hoffmeyer S, Burk O, von Richter O, Arnold HP, Brockmoller J, Johne A, et al. Functional polymorphisms of the human multidrug-resistance gene: multiple sequence variations and correlation of one allele with P-glycoprotein expression and activity in vivo. Proc Natl Acad Sci U S A 2000;97:3473-8.
7. Siddiqui A, Kerb R, Weale ME, Brinkmann U, Smith A, Goldstein DB, et al. Association of multidrug resistance in epilepsy with a polymorphism in the drug-transporter gene ABCB1. N Engl J Med 2003;348:1442-8.
8. Haerian BS, Roslan H, Raymond AA, Tan CT, Lim KS, Zulkifli SZ, et al. ABCB1 C3435T polymorphism and the risk of resistance to antiepileptic drugs in epilepsy: A systematic review and meta-analysis. Seizure 2010;19: 339-46.
9. Labate A, Ventura P, Gambardella A, Le Piane E, Colosimo E, Leggio U, et al. MRI evidence of mesial temporal sclerosis in sporadic "benign" temporal lobe epilepsy. Neurology 2006;66:562-5.
10. Labate A, Cerasa A, Gambardella A, Aguglia U, Quattrone A. Hippocampal and thalamic atrophy in mild temporal lobe epilepsy: A VBM study. Neurology 2008;71:1094-101.
11. Kwan P, Arzimanoglou A, Berg AT, Brodie MJ, Allen Hauser W, Mathern G, et al. Definition of drug resistant epilepsy: consensus proposal by the ad hoc Task Force of the ILAE Commission on Therapeutic Strategies. Epilepsia 2010; 51:1069.
12. Löscher W, Klotz U, Zimprich F, Schmidt D. The clinical impact of pharmaco-genetics on the treatment of epilepsy. Epilepsia 2009;50:1-23.